Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, Storage & Retrieval, LIMS, ELN Software), Application (Drug Discovery, Diagnostics, Genomics & Proteomics), End User – Global Forecast to 2030

Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, Storage & Retrieval, LIMS, ELN Software), Application (Drug Discovery, Diagnostics, Genomics & Proteomics), End User – Global Forecast to 2030

Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, Storage & Retrieval, LIMS, ELN Software), Application (Drug Discovery, Diagnostics, Genomics & Proteomics), End User–Global Forecast to 2030

The global lab automation market is projected to reach $10.54 billion by 2030, at a CAGR of 7.2% from 2023 to 2030.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the increasing pharmaceutical and biotech R&D expenditure, the growing demand for automated labs and instruments, the increasing prevalence of chronic and infectious diseases, and government initiatives supporting life sciences R&D.

Furthermore, growth in genomics & proteomics research, increasing focus on food quality and safety, rising awareness & growing adoption of personalized medicines, and emerging economies provide a significant growth opportunity for this market. However, the high costs of advanced lab automation equipment and funding and infrastructure limitations in developing countries may restrain the growth of this market. Additionally, equipment maintenance and repair and data security and privacy concerns pose a major challenge for the players operating in this market.

Among products, in 2023, the systems segment is expected to account for the largest share of the lab automation market. The large market share of this segment is attributed to the increased focus on drug development, the advantages of automated liquid handling systems to increase efficiency and productivity, reduced manual intervention, increasing prevalence of genetic diseases, and reduced errors.

Among applications, in 2023, the drug discovery segment is expected to account for the largest share of the lab automation market. The increasing pharmaceutical R&D, increased efficiency, high-throughput capability, producing more reproducible results, the ability of lab automation instruments to screen large numbers of compounds, and government initiatives supporting drug discovery and development are expected to boost the growth of this segment.

Among end users, in 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the lab automation market. The large market share of this segment is attributed to factors such as rising demand for new drug discovery and development, growing focus on increasing overall productivity, and initiatives by pharmaceutical and biotechnology companies to expand their research capabilities by opening new research centers.

An in-depth analysis of the geographical scenario of the global lab automation market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India), Latin America, and the Middle East & Africa.

In 2023, North America is expected to account for the largest share of the global lab automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global lab automation market. This growth is primarily driven by the expanding pharmaceutical & biotechnology industry in the region, rapidly improving healthcare infrastructure, increasing pharmaceutical research, and increasing government funding.

The key players operating in the global lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).

Scope of the Report:

Lab Automation Market Assessment–by Product

Systems
Automated Liquid Handling Systems
Automated Nucleic Acid Purification Systems
Automated ELISA Systems
Automated Microplate Readers
Automated Storage and Retrieval Systems
Other Lab Automation Systems

Note: Other lab automation systems include automated incubators, automated cell counters, and cell imaging systems.
Software
Laboratory Information Management Systems (LIMS)
Electronic Lab Notebook (ELN)
Workstation/Equipment Automation Software
Scientific Data Management Systems (SDMS)

Lab Automation Market Assessment–by Application

Drug Discovery
Clinical Diagnostics
Genomics & Proteomics Research
Other Applications

Note: Other applications include bioprocessing in biotechnology, cell analysis, basic research, forensic analysis, and quality control in the F&B industry.

Lab Automation Market Assessment–by End User

Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Other End Users

Note: Other end users include the food & agriculture industry, forensic laboratories, blood banks, and environmental & quality testing.

Lab Automation Market–by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Lab Automation Market - Report Summary

Report Metrics	Details
Years Considered	2021 - 2030
Base Year	2022
Forecast Period	2023-2030
Page Count	244
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Product, Application, End User, and Geography
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Key Companies Mentioned	Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), Hamilton Company (U.S.)

FAQs About the Report

What is the scope of the lab automation market study?

This market study covers the market sizes & forecasts of the lab automation market based on product, application, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the lab automation market at the regional and country levels.

What is the revenue generated from the sale of lab automation products across the globe? At what rate is their demand expected to grow for the next 5–7 years?

The lab automation market is projected to reach $10.54 billion by 2030, at a CAGR of 7.2% during the forecast period of 2023–2030.

What are the various products of lab automation, and which product segment holds the major share market?

Based on product, the lab automation market is segmented into systems and software. In 2023, the systems segment is expected to account for the largest share of the lab automation market due to the advantages of automated instruments, such as high efficiency, accuracy, increased throughput, and reduced manual intervention, along with the elimination of repetitive tasks in laboratories.

What are the various applications involved in lab automation, and which application segment holds the major share of the market?

Based on application, the lab automation market is segmented into drug discovery, clinical diagnostics, genomics and proteomics research, and other applications. In 2023, the drug discovery segment is expected to account for the largest share of the lab automation market due to the high prevalence of chronic and infectious diseases, the ability of automated labs to screen large numbers of compounds, reduce human error, and the ability to gain more reproducible and consistent results.

What are the various end users in the lab automation market, and which end user segment holds the major share of the market?

Based on end user, the lab automation market is segmented into pharmaceutical & biotechnology companies, hospital & diagnostic laboratories, research & academic institutes, and other end users. In 2023, the pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of the lab automation market due to the high pharmaceutical R&D expenditure, rising demand for new drug discovery and development, and initiatives by pharmaceutical and biotechnology companies to expand their research capabilities by opening new research centers.

What are the key factors supporting the growth of this market? What are the major opportunities for the market players in the lab automation market?

The growth of this market is driven by the increasing pharmaceutical and biotech R&D expenditures, the growing demand for automated labs and instruments, the increasing prevalence of chronic and infectious diseases, and government initiatives supporting life sciences R&D.

Furthermore, growth in genomics & proteomics research, the increasing focus on food safety and quality, rising awareness & growing adoption of personalized medicine, and emerging economies are expected to provide significant growth opportunities for the players operating in this market.

What are the factors hindering the growth of the lab automation market?

High costs of advanced lab automation equipment and the funding and infrastructure limitations in developing countries are expected to hinder the growth of this market to a certain extent. In addition, factors such as equipment maintenance and repair and data security and privacy concerns are the major challenges to the growth of this market.

Who are the major players operating in the lab automation market?

The key players operating in the lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), Hamilton Company (U.S.)

Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the lab automation market?

The Asia-Pacific region is slated to witness the fastest growth rate during the forecast period and subsequently offer significant growth opportunities for the players operating in this market. The high market growth in Asia-Pacific is driven by the expanding pharmaceutical biotechnology industry in the region, rapidly improving healthcare infrastructure, increasing pharmaceutical research, and increasing government funding.